Sujal Shah - Jan 25, 2023 Form 4 Insider Report for CymaBay Therapeutics, Inc. (CBAY)

Role
Chief Executive Officer, Director
Signature
/s/ Sujal Shah
Stock symbol
CBAY
Transactions as of
Jan 25, 2023
Transactions value $
$0
Form type
4
Date filed
1/27/2023, 03:27 PM
Previous filing
Jun 7, 2022
Next filing
Oct 10, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CBAY Employee Stock Option (right to buy) Award $0 +800K $0.00 800K Jan 25, 2023 Common Stock 800K $7.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 1/48 of the underlying shares monthly from January 1, 2023.